Corient Private Wealth
ABBV icon

Corient Private Wealth’s AbbVie ABBV Stock Holding History

Corient Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519M Sell
2,063,716
-139,934
-6% -$30.1M 0.72% 21
2026
Q1 		$479M Sell
2,203,650
-186,593
-8% -$41.4M 0.68% 22
2025
Q4 		$546M Buy
2,390,243
+43,777
+2% +$9.97M 0.74% 21
2025
Q3 		$543M Sell
2,346,466
-28,544
-1% -$5.81M 0.86% 19
2025
Q2 		$441M Buy
2,375,010
+84,965
+4% +$15.8M 0.59% 26
2025
Q1 		$480M Sell
2,290,045
-43,870
-2% -$8.53M 0.78% 21
2024
Q4 		$414M Buy
2,333,915
+56,369
+2% +$10.4M 0.69% 25
2024
Q3 		$450M Sell
2,277,546
-31,721
-1% -$5.92M 0.7% 27
2024
Q2 		$396M Buy
2,309,267
+194,691
+9% +$32.3M 0.69% 26
2024
Q1 		$385M Sell
2,114,576
-66,316
-3% -$11.4M 0.69% 31
2023
Q4 		$338M Buy
2,180,892
+151,900
+7% +$22.1M 0.62% 33
2023
Q3 		$302M Sell
2,028,992
-1,140
-0.1% -$167K 0.7% 28
2023
Q2 		$273M Buy
2,030,132
+423,005
+26% +$62M 0.63% 32
2023
Q1 		$256M Buy
1,607,127
+467,514
+41% +$71.5M 0.69% 31
2022
Q4 		$184M Buy
+1,139,613
New +$175M 0.67% 31

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Corient Private Wealth's ABBV Position: Q2 2026 in Review

Corient Private Wealth reduced its AbbVie (ABBV) stake by 6.4% in Q2 2026, selling an estimated $30.1M and leaving 2,063,716 shares worth $519M. The position accounts for 0.72% of the portfolio, ranked #21.

Corient Private Wealth first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $546M in Q4 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Corient Private Wealth held 2,063,716 shares of AbbVie worth $519M as of Q2 2026.
  • Corient Private Wealth sold 139,934 AbbVie shares in Q2 2026, an estimated $30.1M.
  • AbbVie made up 0.72% of Corient Private Wealth's portfolio in Q2 2026, its #21 holding.
  • Corient Private Wealth first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's AbbVie position peaked at $546M in Q4 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.